{"title":"青少年1型糖尿病诊断后一年技术启动时间的差异:一项回顾性队列研究","authors":"Elise Tremblay, Lori Laffel","doi":"10.1177/19322968251345836","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Despite rapidly evolving diabetes technology and evidence that early access to technologies improves outcomes, there is disparate use based on socio-demographic factors. We sought to characterize technology uptake in the year following diagnosis of type 1 diabetes in youth based on race/ethnicity, insurance, and household structure.</p><p><strong>Methods: </strong>We conducted a retrospective cohort study of 692 youth diagnosed with and treated for type 1 diabetes between 2016 and 2020 at a children's hospital. Medical record review provided outcomes of interest, including time to initiation of continuous glucose monitors (CGMs), insulin pump therapy, or both. We used cumulative incidence curves and competing risks regression to compare time to initiation by socio-demographic groups.</p><p><strong>Results: </strong>There were 692 youth, 59% male, diagnosed at a mean age of 10.8 (±4.2) years, in the sample. The majority (83.2%) were White, English-speaking (94.4%), and privately insured (76.7%), with 71.7% living in two-parent households. Cumulative incidence curves and competing risks regression showed that publicly insured youth had a lower likelihood of starting diabetes technologies in the year following diagnosis than privately insured youth. Black and Hispanic youth were less likely than white youth to start CGM and insulin pumps. Youth from non-intact households similarly exhibited lower rates of technology uptake. Hazard ratios for time to both technologies were comparable to those for time to insulin pump.</p><p><strong>Conclusions: </strong>These findings highlight the importance of developing interventions to advance diabetes technology use from onset of type 1 diabetes for all youth.</p>","PeriodicalId":15475,"journal":{"name":"Journal of Diabetes Science and Technology","volume":" ","pages":"19322968251345836"},"PeriodicalIF":4.1000,"publicationDate":"2025-06-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12149155/pdf/","citationCount":"0","resultStr":"{\"title\":\"Disparities in Time to Technology Initiation in the Year Following Diagnosis of Type 1 Diabetes among Youth: A Retrospective Cohort Study.\",\"authors\":\"Elise Tremblay, Lori Laffel\",\"doi\":\"10.1177/19322968251345836\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Despite rapidly evolving diabetes technology and evidence that early access to technologies improves outcomes, there is disparate use based on socio-demographic factors. We sought to characterize technology uptake in the year following diagnosis of type 1 diabetes in youth based on race/ethnicity, insurance, and household structure.</p><p><strong>Methods: </strong>We conducted a retrospective cohort study of 692 youth diagnosed with and treated for type 1 diabetes between 2016 and 2020 at a children's hospital. Medical record review provided outcomes of interest, including time to initiation of continuous glucose monitors (CGMs), insulin pump therapy, or both. We used cumulative incidence curves and competing risks regression to compare time to initiation by socio-demographic groups.</p><p><strong>Results: </strong>There were 692 youth, 59% male, diagnosed at a mean age of 10.8 (±4.2) years, in the sample. The majority (83.2%) were White, English-speaking (94.4%), and privately insured (76.7%), with 71.7% living in two-parent households. Cumulative incidence curves and competing risks regression showed that publicly insured youth had a lower likelihood of starting diabetes technologies in the year following diagnosis than privately insured youth. Black and Hispanic youth were less likely than white youth to start CGM and insulin pumps. Youth from non-intact households similarly exhibited lower rates of technology uptake. Hazard ratios for time to both technologies were comparable to those for time to insulin pump.</p><p><strong>Conclusions: </strong>These findings highlight the importance of developing interventions to advance diabetes technology use from onset of type 1 diabetes for all youth.</p>\",\"PeriodicalId\":15475,\"journal\":{\"name\":\"Journal of Diabetes Science and Technology\",\"volume\":\" \",\"pages\":\"19322968251345836\"},\"PeriodicalIF\":4.1000,\"publicationDate\":\"2025-06-09\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12149155/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Diabetes Science and Technology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1177/19322968251345836\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Diabetes Science and Technology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/19322968251345836","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
Disparities in Time to Technology Initiation in the Year Following Diagnosis of Type 1 Diabetes among Youth: A Retrospective Cohort Study.
Background: Despite rapidly evolving diabetes technology and evidence that early access to technologies improves outcomes, there is disparate use based on socio-demographic factors. We sought to characterize technology uptake in the year following diagnosis of type 1 diabetes in youth based on race/ethnicity, insurance, and household structure.
Methods: We conducted a retrospective cohort study of 692 youth diagnosed with and treated for type 1 diabetes between 2016 and 2020 at a children's hospital. Medical record review provided outcomes of interest, including time to initiation of continuous glucose monitors (CGMs), insulin pump therapy, or both. We used cumulative incidence curves and competing risks regression to compare time to initiation by socio-demographic groups.
Results: There were 692 youth, 59% male, diagnosed at a mean age of 10.8 (±4.2) years, in the sample. The majority (83.2%) were White, English-speaking (94.4%), and privately insured (76.7%), with 71.7% living in two-parent households. Cumulative incidence curves and competing risks regression showed that publicly insured youth had a lower likelihood of starting diabetes technologies in the year following diagnosis than privately insured youth. Black and Hispanic youth were less likely than white youth to start CGM and insulin pumps. Youth from non-intact households similarly exhibited lower rates of technology uptake. Hazard ratios for time to both technologies were comparable to those for time to insulin pump.
Conclusions: These findings highlight the importance of developing interventions to advance diabetes technology use from onset of type 1 diabetes for all youth.
期刊介绍:
The Journal of Diabetes Science and Technology (JDST) is a bi-monthly, peer-reviewed scientific journal published by the Diabetes Technology Society. JDST covers scientific and clinical aspects of diabetes technology including glucose monitoring, insulin and metabolic peptide delivery, the artificial pancreas, digital health, precision medicine, social media, cybersecurity, software for modeling, physiologic monitoring, technology for managing obesity, and diagnostic tests of glycation. The journal also covers the development and use of mobile applications and wireless communication, as well as bioengineered tools such as MEMS, new biomaterials, and nanotechnology to develop new sensors. Articles in JDST cover both basic research and clinical applications of technologies being developed to help people with diabetes.